Logo image
Risk of malignancy including non-melanoma skin cancers with anti-tumor necrosis factor therapy in patients with rheumatoid arthritis: meta-analysis of registries and systematic review of long-term extension studies.
Article de revue scientifique   Avec comité de lecture

Risk of malignancy including non-melanoma skin cancers with anti-tumor necrosis factor therapy in patients with rheumatoid arthritis: meta-analysis of registries and systematic review of long-term extension studies.

Pierre Le Blay, Gaël Mouterde, Thomas Barnetche, Jacques Morel et Bernard Combe
Clinical and experimental rheumatology, Vol.30(5), p.756-64
09/2012
PMID: 22766000

Résumé

Antirheumatic Agents Arthritis, Rheumatoid Registries Risk Assessment Risk Factors Skin Neoplasms Time Factors Tumor Necrosis Factor-alpha Chi-Square Distribution Humans Incidence Odds Ratio
To assess the risk of malignancy in patients with rheumatoid arthritis (RA) receiving tumour necrosis factor (TNF) antagonists through a meta-analysis of data from registry studies and systematic review of long-term extension (LTE) studies.

Fichiers et liens (1)

url
Find in HALAfficher

Indicateurs

1 Consultations de la notice

Détails

Logo image